Trastuzumab deruxtecan is an antibody-drug conjugate (ADC) that contains a humanised anti-. HER2 IgG1 monoclonal antibody (mAb) with the same amino acid ...
Enhertu as monotherapy is indicated for the treatment of adult patients with advanced NSCLC whose tumours have an activating HER2 (ERBB2) mutation and who ...
Enhertu 100 mg powder for concentrate for solution for infusion
www.medicines.org.uk › product › smpc
Enhertu 100 mg powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by Daiichi Sankyo UK Limited.
People also ask
Is Enhertu approved in the EU?
Is Enhertu better than Herceptin?
What class of drug is Enhertu?
What is the discontinuation rate of Enhertu?
ENHERTU is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH positive) breast cancer who have received.